Oaktree Acquisition Corp. III Life Sciences
OACC
$10.44
-$0.01-0.10%
NASDAQ
| 06/30/2025 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Net Income | 12.99% | -- | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | -1.93% | -- | |||
| Change in Net Operating Assets | -66.50% | -- | |||
| Cash from Operations | -93.25% | -- | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -- | -- | |||
| Cash from Financing | -- | -- | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 237.43% | -- | |||